Floorstocks Releases Exclusive Nasdaq MarketSite Interview with Wellgistics Health Inc. (NASDAQ: WGRX)
Watch the full interview on YouTube:
https://youtu.be/gJJlbqd7Mv8
Also streaming at Floorstocks.com:
https://www.floorstocks.com
Hosted by market veteran Kenneth Polcari, the interview unpacks how Wellgistics is modernizing the $600+ billion U.S. prescription drug market—eliminating intermediaries, restoring transparency, and enabling faster, compliant fulfillment from manufacturer to patient.
'This is the kind of story our audience responds to—real revenue, strong leadership, and a disruptive path forward,' said Richard Davis, CEO of Floorstocks. 'The Wellgistics message is timely, clear, and rooted in solving systemic inefficiencies that the market can no longer ignore.'
The conversation highlights Wellgistics' vertically integrated tech stack, growing national footprint, and its AI-powered infrastructure supporting pharmacies, providers, manufacturers, and employer groups.
'We appreciated the opportunity to speak directly to the investor community through Floorstocks,' said Brian Norton, CEO of Wellgistics Health. 'They have our full permission to distribute, quote, and promote this interview. We believe transparency builds trust—and this conversation lays out our vision clearly: fixing a broken system with scalable solutions built for today's healthcare challenges.'
This feature is part of a larger investor education campaign aimed at bringing institutional visibility to Wellgistics Health as it scales its direct distribution network, expands employer carve-out programs, and doubles down on compliant, tech-enabled pharmacy solutions.
About Floorstocks
Floorstocks is a financial media platform connecting high-growth public companies with the next generation of investors. Through exclusive interviews, omnichannel storytelling, and high-impact distribution across YouTube, X (Twitter), Instagram, TikTok, and email, Floorstocks is redefining how public markets are explained to the modern investor. Learn more at www.floorstocks.com.
About Wellgistics Health Inc (NASDAQ: WGRX)
Wellgistics Health moves medications from maker to taker—faster, cheaper, and smarter. Its platform spans wholesale distribution, digital script routing, and hub services like eligibility, prior authorization, adherence, and direct-to-patient fulfillment. A PBM alternative—but PBM-agnostic—WGRX empowers manufacturers, providers, pharmacies, and employer groups with transparent, end-to-end medication access.
Media ContactRichard DavisChief Executive Officer, Floorstocks
[email protected] (212) 555-0192
www.floorstocks.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Meta Platforms, Inc. (META): Jim Cramer Wants Smartglasses To Translate Language
We recently published . Meta Platforms, Inc. (NASDAQ:META) is one of the stocks Jim Cramer recently discussed. Meta Platforms, Inc. (NASDAQ:META)'s shares have gained 21% year-to-date and made it one of the top-performing big tech stocks in 2025. Cramer's previous comments about the firm have pointed out that it has a low earnings multiple despite the 2025 share price gains. He has also attributed Meta Platforms, Inc. (NASDAQ:META)'s performance to its advertising business and strong cost-cutting efforts. However, the CNBC TV host does not believe that the firm is executing well in its AI business. Here are his recent thoughts about Meta Platforms, Inc. (NASDAQ:META), which discussed the firm taking a minority stake in eyewear company Luxottica: '[On a minority stake in Luxottica to boost the metaverse] Well he had it before, remember when I was out with the Luxottica people out in the Hamptons, actually Montauk that's David's area and there was a party there to celebrate the fact that, that they got this deal. I bought the glasses, my most recent doesn't have, it doesn't have the language capacity. Maybe I can downgrade it didn't have it when I was in Belgium, I said tell me this in, give me something in Dutch and it's like sorry I don't speak that. Which was a bummer. But I bought them.' Cramer recently discussed Meta Platforms, Inc. (NASDAQ:META)'s valuation multiple. Here's what he said: 'Meta still has a low multiple. Meta's recreating and. . .remediating the entire advertising business. Along with Amazon and along with YouTube. And Meta's the leader.' While we acknowledge the potential of META as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
an hour ago
- Yahoo
Datadog, Inc. (DDOG) Is Competing With The Rise Of AI, Says Jim Cramer
We recently published . Datadog, Inc. (NASDAQ:DDOG) is one of the stocks Jim Cramer recently discussed. Datadog, Inc. (NASDAQ:DDOG) is a software company that works primarily with cloud computing providers and users. The firm's products allow customers to monitor their platforms in real-time. Datadog, Inc. (NASDAQ:DDOG)'s shares have lost 4% year-to-date, primarily on the back of an 11% dip in July. The shares have lost ground this month because of a downgrade from Guggenheim, which reduced the rating to Sell from Neutral and set a $105 share price target for the company. Cramer discussed how AI has harmed Datadog, Inc. (NASDAQ:DDOG): '[On Morgan Stanley saying Tim Cook's successor could benefit from having a hardware background] Well look, it's funny hardware is part of the, I'm glad you mentioned hardware, hardware's part of the issue of how NVIDIA got to where it is. This is an essentially, there's a belief in many people on Wall Street and in Silicon Valley, that hardware prevails here because we're gonna get rid of a huge number of people who would do SaaS, you know, software as a service, and that includes, yes, Salesforce, includes ServiceNow, includes DataDog which got out of the S&P. Because there are going to be fewer and fewer people who are actually in the organization who need that.' A close-up of a laptop with a software engineer coding on the monitor. Baron Funds mentioned Datadog, Inc. (NASDAQ:DDOG) in its Q1 2025 investor letter. Here is what the fund said: 'Most of our companies do not sell goods but instead provide critical services to their Inc. (NASDAQ:DDOG), the leading cloud-based observability platform, has seen its stock decline by over 30% year-to-date because its revenues are based on consumption/usage and would likely be impacted by any significant cyclical downturn. However, its competitive position has gotten stronger, its market share is continuing to rise, and it is indexed to promising long-term secular trends of cloud adoption and accelerating app development, and is well positioned for AI as the critical central IT infrastructure platform for its customers.' While we acknowledge the potential of DDOG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
CoreWeave, Inc. (CRWV) Is Confident About NVIDIA's AI GPU Demand, Says Jim Cramer
We recently published . CoreWeave, Inc. (NASDAQ:CRWV) is one of the stocks Jim Cramer recently discussed. CoreWeave, Inc. (NASDAQ:CRWV) is an AI and cloud computing infrastructure provider. It is one of the strongest-performing stocks of 2025 as the shares have gained 226% since their IPO in March. CoreWeave, Inc. (NASDAQ:CRWV) has benefited from market optimism about AI as investors believe that the firm can benefit from sustained long-term AI demand and its early mover advantage in the AI infrastructure space. CoreWeave, Inc. (NASDAQ:CRWV) also recently announced that it would acquire Core Scientific, and Cramer commented that the deal made him optimistic about the overall dealmaking environment in America. Here are his recent remarks about CoreWeave, Inc. (NASDAQ:CRWV): 'You speak to CoreWeave, you speak to Michael Entrator, who's a terrific guy. Uh, he would say look, we can't put 'em up fast enough. And, we are, they're valuable even after they do not have the latest and greatest. People do not understand that. This is not the 386 going to the 46 going to the Pentium, you can't throw these away. They work. There's always some use for even the oldest ones. So they pay themselves back.' In his earlier remarks, Cramer commented on CoreWeave, Inc. (NASDAQ:CRWV)'s latest deal and his meetings with management: 'Yes and they're all over me today. CoreWeave is saying that this helps them immensely in terms of the amount of power they have and it's actually a good deal for their finances. The stock's turned up, they were up big on, well CoreWeave was up big, and it's given back that. This is the kind of deal that if I were Lina Khan at the FTC, I would say wait a second, Core and Core? No. We will not let a core merge with a core. . . No I mean to being facetious, but not really, in someways because I think she would say these are two companies that could compete. Which is true. But I think that this is the kind of deal that we ought to get used to having. It's one of the things that makes me bullish. Which is that there's not any, you know you can make a deal if you think it's rational and not expect to be challenged. Now someone might say, you know Jim, that was really a cheap shot. No. The deference was cheap. The deference. 'I've got Michael Entrator. He has done a remarkable job, I don't know if people care about CoreWeave anymore, but, Michael Entrator's stock opened, it was at 40 and it went up to 156! You know, did people who buy that make money or did they just kind of say you know what, I'm glad I have my index fund but by the way, no. Ben Stoto and I were very positive on CoreWeave after meeting with the company and spending some time with them. Just very impressive people who were doubted and are doubted, there's a very big short position. But you know what, they figured they have a, when you ask NVIDIA what do you think of them, and NVIDIA bought a quarter of that IPO, NVIDIA would say great partner, great partner. While we acknowledge the potential of CRWV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
